Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Impact of Smoking Status on Hospital Outcome of Patients with ST-Segment Elevation Myocardial Infarction Either Treated by Pharmacy-invasive Strategy or Primary  Percutaneous Coronary Intervention .

View through CrossRef
Abstract Background: Smoking is a common public problem with a high health burden. Many studies have shown that there are many hazardous actions of smoking on body systems especially haemostatic, respiratory and circulatory systems.Smoking may increase the thrombus burden in patients with acute coronary syndrome. The ‘smoker’s paradox’ has been described for more than 25 years. Its existence and its effect on patients’ outcome post myocardial infarction are debatable. So we conducted our study to assess the impact of smoking status on outcome of STEMI patients and efficacy of pharmaco-invasive strategy in treating STEMI patients compared to PPCI. Methods: We conducted our prospective observational study in the Cardiology department from-August 2018 to August 2019 on patients who are presented by STEMI with the duration from onset of symptoms to first medical contact were 12 hours or less we included 199 patients in our study.Patients are divided into 4 groups Group 1(Smokers treated by PPCI) Group 2 (Non-smokers treated by PPCI) Group 3 (Smoker treated by pharmaco-invasive strategy)Group 4 (Non-smoker treated by pharmaco-invasive strategy) TIMI flow before and after PCI, acute heart failure and death was assessed in each patient.Results:Smokers are younger than non-smokers and have fewer co-morbidities. Patients treated by primary PCI and pharmaco-invasive strategy either smokers and non-smokers there was no significant difference between the 4 groups in angiographic data and outcome except that smokers treated by pharmaco-invasive strategy had a lower incidence of TIMI flow III at diagnostic angiography before PCI with P value (0.047 ) Conclusion: There is no actual smokers paradox. Pharmaco-invasive strategy is a good option when a PPCI is not available. Finally, early transfer of smokers treated with a pharmaco-invasive strategy to a PCI capable hospital for early intervention may be recommended.
Springer Science and Business Media LLC
Title: Impact of Smoking Status on Hospital Outcome of Patients with ST-Segment Elevation Myocardial Infarction Either Treated by Pharmacy-invasive Strategy or Primary  Percutaneous Coronary Intervention .
Description:
Abstract Background: Smoking is a common public problem with a high health burden.
Many studies have shown that there are many hazardous actions of smoking on body systems especially haemostatic, respiratory and circulatory systems.
Smoking may increase the thrombus burden in patients with acute coronary syndrome.
The ‘smoker’s paradox’ has been described for more than 25 years.
Its existence and its effect on patients’ outcome post myocardial infarction are debatable.
So we conducted our study to assess the impact of smoking status on outcome of STEMI patients and efficacy of pharmaco-invasive strategy in treating STEMI patients compared to PPCI.
Methods: We conducted our prospective observational study in the Cardiology department from-August 2018 to August 2019 on patients who are presented by STEMI with the duration from onset of symptoms to first medical contact were 12 hours or less we included 199 patients in our study.
Patients are divided into 4 groups Group 1(Smokers treated by PPCI) Group 2 (Non-smokers treated by PPCI) Group 3 (Smoker treated by pharmaco-invasive strategy)Group 4 (Non-smoker treated by pharmaco-invasive strategy) TIMI flow before and after PCI, acute heart failure and death was assessed in each patient.
Results:Smokers are younger than non-smokers and have fewer co-morbidities.
Patients treated by primary PCI and pharmaco-invasive strategy either smokers and non-smokers there was no significant difference between the 4 groups in angiographic data and outcome except that smokers treated by pharmaco-invasive strategy had a lower incidence of TIMI flow III at diagnostic angiography before PCI with P value (0.
047 ) Conclusion: There is no actual smokers paradox.
Pharmaco-invasive strategy is a good option when a PPCI is not available.
Finally, early transfer of smokers treated with a pharmaco-invasive strategy to a PCI capable hospital for early intervention may be recommended.

Related Results

Cardio protective effect of nicorandil in reperfusion injury among patients undergoing primary percutaneous coronary intervention
Cardio protective effect of nicorandil in reperfusion injury among patients undergoing primary percutaneous coronary intervention
Objectives: To evaluate the effect of nicorandil in prevention of reperfusion injury during primary percutaneous coronary intervention by thrombolysis in myocardial infarction flow...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract Introduction Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract Introduction Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...

Back to Top